| Titan Biotech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524717 |
NSE Symbol : - |
P/E(TTM) : 53.43 |
|
ISIN Demat : INE150C01029 |
Div & Yield% : 0.13 |
EPS(TTM) : 7.44 |
|
Book Value(₹) : 41.35 |
Market Cap(₹Cr) : 1,642.41 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 59.17 | 48.83 | 56.51 | 54.35 | 46.50 | 35.17 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 59.17 | 48.83 | 56.51 | 54.35 | 46.50 | 35.17 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.81 | 2.11 | 1.26 | 1.32 | 0.72 | 1.38 |
| Total Income | 60.98 | 50.94 | 57.76 | 55.68 | 47.22 | 36.55 |
| Total Expenditure | 46.68 | 39.12 | 45.68 | 45.03 | 37.76 | 30.60 |
| PBIDT | 14.30 | 11.82 | 12.09 | 10.65 | 9.46 | 5.95 |
| Interest | 0.20 | 0.24 | 0.26 | 0.22 | 0.20 | 0.08 |
| PBDT | 14.10 | 11.58 | 11.83 | 10.43 | 9.26 | 5.87 |
| Depreciation | 1.37 | 1.30 | 1.27 | 1.21 | 1.15 | 0.84 |
| Tax | 3.22 | 3.02 | 2.63 | 2.32 | 1.92 | 1.25 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.06 | 0.70 | 0.07 | 0.04 | 0.03 | 0.02 |
| Reported Profit After Tax | 9.46 | 6.56 | 7.87 | 6.86 | 6.16 | 3.77 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 9.46 | 6.56 | 7.87 | 6.86 | 6.16 | 3.77 |
| EPS (Unit Curr.) | 2.29 | 1.59 | 9.52 | 8.30 | 7.46 | 4.56 |
| EPS (Adj) (Unit Curr.) | 2.29 | 1.59 | 1.90 | 1.66 | 1.49 | 0.91 |
| Calculated EPS (Unit Curr.) | 2.29 | 1.59 | 9.52 | 8.30 | 7.46 | 4.56 |
| Calculated EPS (Adj) (Unit Curr.) | 2.29 | 1.59 | 1.90 | 1.66 | 1.49 | 0.91 |
| Calculated EPS (Ann.) (Unit Curr.) | 9.15 | 6.35 | 38.09 | 33.22 | 29.82 | 18.23 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 9.15 | 6.35 | 7.62 | 6.64 | 5.96 | 3.65 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 8.26 | 8.26 | 8.26 | 8.26 | 8.26 | 8.26 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 24.17 | 24.21 | 21.39 | 19.60 | 20.34 | 16.92 |
| PBDTM(%) | 23.83 | 23.71 | 20.93 | 19.19 | 19.91 | 16.69 |
| PATM(%) | 15.99 | 13.43 | 13.93 | 12.62 | 13.25 | 10.72 |
